Artificial Intelligence Adoption in Healthcare

| February 10, 2020

article image
Artificial intelligence (AI) – long an impactful technology in other industries – is in the midst of rapid adoption across the healthcare industry. What was once seen as having great potential is now making its way to real-world implementation, driving improvements in care through enhanced clinical decision support, empowering payers, providers and healthcare organizations across the ecosystem with actionable insight. Patient-generated behavioral data is becoming increasingly common for care management. Smart gadgets such as Fitbits, smartphones and other wearable sensors collect patients’ data, helping patients and physicians better understand habits and set realistic healthcare goals.

Spotlight

Merck

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases.

OTHER ARTICLES

A snapshot of the precision medicine landscape

Article | March 4, 2020

The global market for precision medicine is projected to top more than $84.5 billion by 2024. Targeted therapies for rare, genetic diseases, cancer and chronic conditions come with the hope of a cure. Companies such as Roche, Novartis, Spark Therapeutics, Pfizer, Editas and BioMarin are among the pharma players in this space. There seem to be new developments in precision medicine on almost a weekly basis. So what do educational institutions need to do to create fertile ground for gene therapy research to produce the next generation of companies developing these therapies? And what needs to happen to facilitate data sharing, ensure access to genome sequencing and these promising therapies?

Read More

Health IT coalition to use data analytics in battle against COVID-19

Article | April 2, 2020

Healthcare organizations, technology firms, nonprofits, and academia are banding together to use their collective expertise, data, and insights for rapid deployment of innovative, open-source solutions to the global pandemic. The COVID-19 Healthcare Coalition, a private-sector led response, aims to mitigate the worst effects of the coronavirus by flattening the curve. A key component of this effort will be the use of real-time data for analytics that will help preserve the healthcare delivery system. LUMEDX client partners HCA Healthcare, the Mayo Clinic, and Intermountain Healthcare have joined big tech companies such as Amazon, Google, Microsoft, and others. For a full list, visit the website here. All coalition work is voluntary, and members are asked to pledge open cooperation and sharing. In addition to combining the best sources of information from around the world to provide data, analytics and insights to all, the coalition’s priorities include

Read More

Healthcare Data Infrastructure Security Cannot Be Ignored During A Pandemic

Article | April 2, 2020

The rapid advancement of technology has inspired hope in the healthcare industry, promising to employ artificial intelligence (AI) and cloud-based data platforms in life-altering ways. Surgery assisting robots and miraculously accurate AI-based cancer diagnosis methods are a few preliminary examples of what the industry can expect. With all these great technological strides being taken, however, compliance can easily be left in the dust. And with COVID-19 pushing the limits of healthcare systems worldwide, it’s too easy for cybersecurity to become a lesser priority.The situation is bleak, with nearly 17,000 patient records being breached every day, according to Entech. Healthcare democratization is essential to fully harnessing the power of AI and other tech advancements on the horizon, which require compliant data distribution and the application of insights gathered from it. Healthcare institutions are struggling to not only meet basic privacy and compliance laws but have difficulty leveraging the large amounts of data that they store in a meaningful way.

Read More

How to Develop An ABM Strategy for Healthcare and Life Sciences

Article | March 5, 2020

Most physician outreach now takes place digitally or indirectly. This shift in engagement has made it crucial for sales and marketing teams in healthcare and life sciences (HLS) to be aligned with a unified strategy. That’s what we discovered at League. Founded in 2014, League is on a mission to consumerize health and benefits for employers. We started using Salesforce and Pardot in 2017. Back then, marketing and sales were disconnected, and this was impacting our overall performance in a negative way. Our solution was to develop our first account-based marketing strategy. We saw that ABM was a huge trend, and we loved the idea of choosing a set of target accounts, creating playbooks, and personalizing marketing campaigns to help drive meetings. Here’s how we adopted ABM at League, and the results of our ABM efforts.

Read More

Spotlight

Merck

Merck is a leading global biopharmaceutical company that has been inventing for life for more than a century, bringing forward medicines and vaccines for many of the world’s most challenging diseases.

Events